WHO Consolidated Guidelines on HIV Testing Services

WHO Consolidated Guidelines on HIV Testing Services
This document provides a new recommendation to support HTS by trained lay providers, considers the potential of HIV self-testing to increase access to and coverage of HIV testing, and outlines focused and strategic approaches to HTS that are needed to support the new UN 90 –90 –90 global HIV targets. 

The majority of information on gay men and other men who have sex with men and transgender people can be found beginning on page 69.

Year of publication: 
2015

UNAIDS Supplement Tool to Set and Monitor Targets for HIV Prevention, Diagnosis, Treatment, and Care for Key Populations

UNAIDS Supplement Tool to Set and Monitor Targets for HIV Prevention, Diagnosis, Treatment, and Care for Key Populations
This document is the supplement to the consolidated guidelines on HIV prevention, diagnoses, treatment and care for key populations, in which WHO brings together all existing guidance relevant to key populations- gay men and men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers, and transgender people.
Year of publication: 
2014, 2015

Prevention and Treatment of HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men and Transgender People

Prevention and Treatment of HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men and Transgender People
These guidelines include evidence-based recommendations, the summary and grading of evidence, implementation issues, and key research gaps. The document presents good practice recommendations that focus on ensuring an enabling environment for the recognition and protection of the human rights of MSM and transgender people.
Year of publication: 
2011

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations

Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations
In these 2014 consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations, the World Health Organization (WHO) brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers, and transgender people – and updates selected guidance and recommendations. These guidelines aim to: provide a comprehensive package of evidence-based HIV-related recommendations for all key populations; increase awareness of the needs of and issues important to key populations; improve access, coverage and uptake of effective and acceptable services; and catalyze greater national and global commitment to adequate funding and services.

Guidance on Prevention of Viral Hepatitis B & C among People Who Inject Drugs

Guidance on Prevention of Viral Hepatitis B & C among People Who Inject Drugs
This guidance on prevention of viral hepatitis B and C among people who inject drugs is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention, and treatment by the World Health Organization. These recommendations are based on systematic reviews of scientific evidence, community values, and preferences and implementation issues.

The focus of this guidance is on low- and middle-income countries, but it applies equally to high-income settings. The WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users presents a comprehensive package of interventions for HIV prevention, treatment and care for people who inject drugs. This document has helped to achieve global consensus with high-level political bodies, the United Nations, donor agencies and civil society organizations on adopting a public health response that best addresses HIV in countries facing epidemics of injecting drug use. The nine interventions of this package (see box) are also relevant to the prevention of viral hepatitis, in particular the first two, needle and syringe programmes and opioid substitution therapy.

Prévention et traitement du VIH et des autres infections sexuellement transmissibles chez les travailleuses du sexe dans les pays à revenu faible ou intermédiaire

Prévention et traitement du vih et des autres infections sexuellement transmissibles chez les travailleuses du sexe dans les pays à revenu faible ou intermédiaire
Le présent document contient des recommandations techniques sur les interventions qui permettent de prévenir et de traiter efficacement le VIH et les autres IST chez les travailleuses du sexe et leurs clients. Ces recommandations s’adressent aux responsables nationaux de la santé publique et aux administrateurs des programmes de lutte contre le VIH/sida et les IST, aux organisations non gouvernementales, y compris les organisations communautaires et appartenant à la société civile, ainsi qu’aux agents de santé. Les Régions et les pays sont encouragés à les adapter pour assurer des services acceptables pour les travailleuses du sexe en tenant compte du contexte épidémiologique et social. Elles pourront aussi intéresser les organismes de financement internationaux, les médias scientifiques, les responsables des politiques de santé et les personnes qui militent en faveur de la santé.

Prévention et traitement de l’infection à vih et des autres infections sexuellement transmissibles chez les hommes ayant des rapports sexuels avec d’autres hommes et chez les personnes transgenres

Prévention et traitement de l'infection à vih et des autres infections sexuellement transmissibles chez les hommes ayant des rapports sexuels avec d'autres hommes et chez les personnes transgenres
Cette directive fournira des recommandations pour les partenaires régionaux et nationaux sur appropriée interventions visant à répondre aux besoins des HSH et transgenres. Il fournit également un occasion de souligner et de mettre l’accent sur la corrélation entre la prévention et de traitement en la réponse à l’épidémie de VIH chez les HSH et les personnes transgenres, en particulier à la lumière de plus en plus évident sur ​​le bénéfice préventif de la thérapie antirétrovirale (ART ). Ceci peut conduire à une réduction substantielle de la transmission au niveau de la population.
Year of publication: 
2011